Spots Global Cancer Trial Database for EndoMAXX Endoluminal Valve Technology (EVT) Compared to EndoMAXX
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: EndoMAXX Endoluminal Valve Technology (EVT) Compared to EndoMAXX
Official Title: Prospective, Multicenter, Single Blind, Randomized Study Comparing the EndoMAXX Endoluminal Valve Technology (EVT) Fully Covered Esophageal Stent With Valve to the EndoMAXX Fully Covered Esophageal Stent for Malignant Strictures Requiring Stent Placement Across the Gastroesophageal Junction
Study ID: NCT02159898
Conditions
Study Description
Brief Summary: This is a prospective, single blinded, randomized study of EndoMAXX Endoluminal Valve Technology (EVT) Fully Covered Esophageal Stent with Valve for the treatment of malignant strictures of the lower esophagus. The purpose of this study is to evaluate improvement of dysphagia due to esophageal stricture with EndoMAXX Endoluminal Valve Technology (EVT) Fully Covered Esophageal Stent with Valve (investigational device) compared to the EndoMAXX Fully Covered Esophageal Stent (reference device).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Colorado Denver, Aurora, Colorado, United States
University of Florida, Gainesville, Florida, United States
Indiana University, Indianapolis, Indiana, United States
Mayo Clinic, Rochester, Minnesota, United States
Weill Cornell Medical College, New York, New York, United States
Geisinger Medical Center, Danville, Pennsylvania, United States
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact Details
Name: Kulwinder DUA, MD
Affiliation: Medical College of WI
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
